Center for Clinical and Epidemiological Research, Universidade de São Paulo, São Paulo, SP 05508-000, Brazil.
Department Internal Medicine, Universidade de São Paulo, São Paulo, SP 05508-000, Brazil.
J Clin Endocrinol Metab. 2024 Jan 18;109(2):e698-e710. doi: 10.1210/clinem/dgad539.
The presence of thyroid peroxidase antibodies (TPOAbs) may be considered as an indicator of adverse health outcomes.
We aimed to investigate the potential determinants of TPOAb levels and to analyze the association between TPOAb titers and the risk of all- and specific-cause mortality.
Baseline and longitudinal data of 13 187 participants from the ELSA-Brasil Study were analyzed. We investigated the association of TPOAb, detectability, positivity, and persistent positivity with sociodemographic and lifestyle factors using logistic regressions. Cox proportional hazards and Fine-Gray subdistribution hazard regression analyses were used to verify the association of TPOAbs with mortality.
The determinants of TPOAb detectability and positivity were younger age, higher body mass index, female sex, and former and current smoking status. Black, mixed, and other self-reported races, intermediate and higher education, and heavy drinking were determinants of detectable and positive TPOAb levels. Female sex, White race, and former smoking were determinants of persistent TPOAb positivity at 2 visits, although only the female sex maintained its association at 3 visits. Moreover, after multivariate adjustment, there were associations between higher levels of TPOAbs and higher risk of cancer-related mortality among men, and TPOAb detectability and mortality by other causes among women.
Sociodemographic and lifestyle-related factors were determinants of multiple TPOAb categories. TPOAb levels were associated with mortality risk; however, the low mortality rate in this sample might have compromised this finding. We suggest further studies to explore the clinical importance of detectable TPOAb levels, not only its positivity, as a potential marker of inflammation.
甲状腺过氧化物酶抗体 (TPOAb) 的存在可能被视为不良健康结局的指标。
我们旨在研究 TPOAb 水平的潜在决定因素,并分析 TPOAb 滴度与全因和特定原因死亡率风险之间的关联。
分析来自 ELSA-Brasil 研究的 13187 名参与者的基线和纵向数据。我们使用逻辑回归调查 TPOAb、可检测性、阳性和持续阳性与社会人口统计学和生活方式因素的关联。使用 Cox 比例风险和 Fine-Gray 亚分布风险回归分析来验证 TPOAbs 与死亡率的关联。
TPOAb 可检测性和阳性的决定因素是年龄较小、体重指数较高、女性和以前及现在的吸烟状况。黑种人、混血和其他自我报告的种族、中等和高等教育以及大量饮酒是可检测和阳性 TPOAb 水平的决定因素。女性、白种人以及以前的吸烟是 2 次就诊时 TPOAb 持续阳性的决定因素,尽管只有女性在 3 次就诊时保持了这种关联。此外,在多变量调整后,TPOAb 水平较高与男性癌症相关死亡率风险增加以及女性 TPOAb 可检测性与其他原因死亡率之间存在关联。
社会人口统计学和生活方式相关因素是多种 TPOAb 类别的决定因素。TPOAb 水平与死亡率风险相关;然而,由于该样本的死亡率较低,可能会影响这一发现。我们建议进一步研究以探索可检测 TPOAb 水平的临床重要性,而不仅仅是其阳性率,作为炎症的潜在标志物。